Reckitt Benckiser Group Plc (LON:RB)‘s stock had its “neutral” rating restated by equities research analysts at J P Morgan Chase & Co in a report issued on Monday, November 6th.
RB has been the subject of a number of other research reports. Liberum Capital dropped their price target on Reckitt Benckiser Group Plc from GBX 8,700 ($114.43) to GBX 8,000 ($105.22) and set a “buy” rating for the company in a research report on Wednesday, October 25th. Royal Bank Of Canada set a GBX 5,600 ($73.66) price target on Reckitt Benckiser Group Plc and gave the company a “sell” rating in a research report on Friday, October 20th. Jefferies Group LLC dropped their price objective on Reckitt Benckiser Group Plc from GBX 8,150 ($107.19) to GBX 7,500 ($98.65) and set a “hold” rating for the company in a research report on Friday, September 15th. Morgan Stanley set a £100 ($131.53) price objective on Reckitt Benckiser Group Plc and gave the stock a “buy” rating in a research report on Wednesday, October 11th. Finally, Societe Generale set a GBX 7,800 ($102.59) price target on Reckitt Benckiser Group Plc and gave the stock a “neutral” rating in a research report on Tuesday, September 5th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have issued a buy rating to the company’s stock. Reckitt Benckiser Group Plc presently has an average rating of “Hold” and an average target price of GBX 7,785 ($102.39).
Shares of Reckitt Benckiser Group Plc (LON:RB) opened at GBX 6,492 ($85.39) on Monday. Reckitt Benckiser Group Plc has a fifty-two week low of GBX 63.53 ($0.84) and a fifty-two week high of GBX 8,110.43 ($106.67).
COPYRIGHT VIOLATION NOTICE: This article was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://ledgergazette.com/2017/11/23/reckitt-benckiser-group-plcs-rb-neutral-rating-reaffirmed-at-j-p-morgan-chase-co.html.
In other news, insider Adrian Nevil Hennah acquired 2,285 shares of the firm’s stock in a transaction on Wednesday, November 8th. The stock was purchased at an average price of GBX 6,567 ($86.37) per share, for a total transaction of £150,055.95 ($197,364.13). Also, insider Christopher Sinclair acquired 2,800 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was purchased at an average price of GBX 6,597 ($86.77) per share, with a total value of £184,716 ($242,951.47).
Reckitt Benckiser Group Plc Company Profile
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.